Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Gemtesa is approved for men with overactive bladder symptoms who are receiving pharmacologic treatment for benign prostatic hyperplasia.

There’s no shame in Ariana Grande’s game. The Wicked actress got candid and acknowledged a few cosmetic procedures. The ...

Some individuals find complementary therapies helpful in managing bladder control issues. Acupuncture shows promise in reducing overactive bladder symptoms and stress incontinence. However, results ...

Sunobinop tosylate is under clinical development by Imbrium Therapeutics and currently in Phase I for Overactive Bladder.

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Per the health service’s site, “Fruit juices, such as grapefruit and orange, are acidic and can irritate your bladder.” They ...